Before they can move ahead with their deal, drug makers Teva and Cephalon must provide the Federal Trade Commission with additional information related to Teva's pending acquisition of Cephalon.

Another generic drug maker has been given the green light to market its version of an Alzheimer's disease treatment.

Pfizer has filed suit against generic drug maker Impax Labs in connection with the latter’s attempt to market a generic drug for bladder problems.

A generic drug maker has been granted approval from the Food and Drug Administration to manufacture its version of a urinary tract infection treatment.

Generic drug maker Par has inked a definitive agreement to acquire an India-based developer and manufacturer of generic drugs.

Sandoz is looking to market a generic version of a Shire drug for treating attention deficit hyperactivity disorder.

Drug maker Mylan has launched a generic treatment for muscle spasms, the company said Friday.

The Generic Pharmaceutical Association and other trade and patient advocacy groups can push generic drug usage as a way to save on medical costs, but throwing the weight of Congress behind generics gives them a bigger boost than ever.

Alza Corp. is attempting to block Impax Labs from developing a generic version of Alza's attention deficit hyperactivity disorder treatment.

Cephalon has another suitor in the form of the world’s largest generic drug company.

A generic drug maker is being sued for patent infringement for its version of a fixed-dose combination drug co-created by Pozen and AstraZeneca.

The main trade group for the generic drug industry is heralding a new cost analysis by the IMS Institute for Healthcare Informatics showing that generic drugs can reduce co-payments by up to 80%.